Hennion & Walsh Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Sell |
19,567
-465
| -2% | -$32.1K | 0.05% | 420 |
|
|
2025
Q1 | $1.39M | Buy |
20,032
+290
| +1% | +$20.1K | 0.06% | 379 |
|
|
2024
Q4 | $1.7M | Buy |
19,742
+1,701
| +9% | +$146K | 0.08% | 327 |
|
|
2024
Q3 | $2.15M | Buy |
18,041
+9,272
| +106% | +$1.1M | 0.1% | 262 |
|
|
2024
Q2 | $1.25M | Buy |
8,769
+2,159
| +33% | +$308K | 0.06% | 373 |
|
|
2024
Q1 | $849K | Buy |
+6,610
| New | +$849K | 0.05% | 460 |
|